Gestational diabetes screening: clinical timeline and criteria

The reason is that pregnancy-related insulin resistance tends to increase as pregnancy progresses, so testing in this window can detect changes that may not have been present earlier.

A screening result is also not always a diagnosis. Depending on the clinical protocol used, you may have an initial glucose challenge followed by a longer confirmatory test, or one diagnostic test that checks several blood sugar levels. Knowing which pathway your care team uses—and what each result can and cannot tell you—makes the next steps easier to navigate.

Standard screening window and early risk assessment

For pregnant people without pre-existing diabetes, universal screening for gestational diabetes mellitus (GDM) is generally offered at 24–28 weeks. This is the standard window used to identify glucose intolerance that develops during pregnancy.

Your clinician may assess your risk earlier in prenatal care. A history of gestational diabetes, known elevated blood sugar, or other clinical risk factors can lead to early testing for previously unrecognized type 2 diabetes or diabetes that began before pregnancy. That early assessment has a different purpose from routine GDM screening: it looks for diabetes that may already be present, rather than assuming that GDM screening should happen early for everyone.

For people who are asymptomatic and do not have a known high-risk indication, routine GDM screening before 24 weeks is not generally recommended by ACOG and the U.S. Preventive Services Task Force, because evidence of benefit is insufficient. The best plan depends on your medical history and the results of any prior testing, so it is reasonable to ask what an early test is intended to detect.

The 24–28 week window is the usual point for routine GDM screening; an earlier test is generally aimed at identifying pre-existing or early diabetes in people with higher risk.

If you are told that your blood sugar is elevated early in pregnancy, ask whether the result meets criteria for diabetes outside pregnancy, whether a repeat or different test is needed, and how the finding changes your prenatal care. The label and follow-up plan matter because the timing of the abnormal result affects how clinicians interpret it.

The two-step pathway: from a 50 g challenge to a 100 g OGTT

In the two-step approach, screening begins with a non-fasting 50 g oral glucose challenge test (GCT). You drink a glucose solution, then have blood drawn one hour later. This first test is a screen: it identifies people who may need a diagnostic test, but a result above the screening cutoff does not, by itself, establish GDM.

Practices commonly use a one-hour cutoff of 130, 135, or 140 mg/dL. The threshold can vary by clinic, so a result that triggers follow-up in one practice may not do so in another. Your care team should interpret the number using the cutoff in its protocol, rather than treating the cutoff as a universal line.

If your GCT result reaches or exceeds the clinic’s cutoff, the next step is typically a 100 g, three-hour oral glucose tolerance test (OGTT). This test usually requires fasting beforehand. After a fasting blood draw, you drink the glucose solution and have blood samples collected at one, two, and three hours. Follow the lab’s instructions about fasting, medications, and what to eat or drink before the appointment; preparation can affect how results are interpreted.

Under Carpenter–Coustan criteria, GDM is diagnosed when at least two of the four measurements meet or exceed the specified thresholds:

Some protocols use different criteria, including National Diabetes Data Group thresholds, so the laboratory report alone may not show the full context. Ask which standard your clinician uses and how many abnormal values are required. Under Carpenter–Coustan criteria, one elevated value is generally not enough to diagnose GDM; two or more are required.

The three-hour test can be inconvenient, and some people feel nauseated after drinking the glucose solution. If you vomit or cannot complete the test, contact the clinic rather than trying to interpret an incomplete result yourself. Your care team can explain whether the test should be rescheduled or whether another approach is appropriate.

The one-step pathway: a 75 g, two-hour OGTT

Some clinicians use a one-step approach instead of the initial challenge test followed by a longer diagnostic test. In this pathway, you fast before drinking a 75 g glucose solution, then have blood measured while fasting and at one and two hours.

The IADPSG criteria, also accepted by the American Diabetes Association, diagnose GDM when a single value meets or exceeds its threshold:

The one-step test uses different glucose doses, timing, and diagnostic rules from the two-step approach. That is why numbers from the two pathways should not be compared as if they were interchangeable. A fasting value of 93 mg/dL, for example, meets the IADPSG fasting threshold, while interpretation under another protocol depends on that protocol’s criteria and the rest of the test.

Which method you receive may depend on the practice’s adopted guidelines and local workflow. If you move between care settings during pregnancy, let each team know which test you completed and share the actual results, including the timing of each blood draw. A summary such as “the glucose test was normal” may not give a new clinician enough detail to interpret follow-up correctly.

Making sense of results and the next clinical step

A screening result and a diagnostic result answer different questions. The 50 g GCT estimates whether a full diagnostic test is needed. The OGTT measures glucose at multiple time points under a defined protocol, and the number of elevated values required for diagnosis depends on the chosen criteria.

When you review a result with your clinician, these details help put it in context:

• Which test was performed: a non-fasting 50 g, one-hour screening challenge; a fasting 100 g, three-hour OGTT; or a fasting 75 g, two-hour OGTT.
• The exact values and collection times: fasting, one hour, two hours, and, when applicable, three hours.
• The criteria used: Carpenter–Coustan, National Diabetes Data Group, or IADPSG thresholds.
• The clinic’s cutoff for the initial screen: commonly 130, 135, or 140 mg/dL for the one-hour 50 g challenge.
• What happens next: whether you need a diagnostic test, additional counseling, or routine follow-up based on the result.

If you receive a result close to a threshold, it is understandable to want a simple yes-or-no answer. The interpretation still depends on the full test and the protocol. A single number outside a reference range does not mean that every pathway will give you the same diagnosis, and one elevated value on a 100 g OGTT should not automatically be presented as diagnostic under Carpenter–Coustan criteria.

Once GDM is diagnosed, your care team can discuss how to monitor blood sugar and what additional prenatal support may be appropriate. The details of management are individualized; the screening result is the start of a care plan, not a prediction that your pregnancy will follow a particular course.

After birth: follow-up still matters

Blood sugar often changes after delivery, but a history of GDM remains relevant to your future health. ACOG and ADA recommend screening for persistent abnormal glucose tolerance or type 2 diabetes 4–12 weeks postpartum, using a two-hour OGTT. This follow-up checks whether glucose has returned to the expected range or whether elevated levels remain after pregnancy.

Postpartum testing can be easy to lose sight of while you are recovering and caring for a newborn. Before leaving prenatal care, ask who will order the test, when it should happen, and where the results will be reviewed. If you miss the recommended window, contact your clinician to make a plan rather than assuming that testing is no longer useful.

A GDM diagnosis also gives your primary care clinician important context for future screening. Keep a copy of your pregnancy test results and the postpartum OGTT result, and mention the history when you receive routine care. That record helps connect pregnancy-related glucose changes with your longer-term metabolic health.

The practical route is straightforward: establish whether early testing is indicated for your history, confirm which screening pathway your practice uses, and review results against that pathway’s specific thresholds. At your next visit, ask your clinician: “Which test and diagnostic criteria are we using, and what is the next step if one or more of my values are elevated?”